Canadian researchers have found.

Canadian researchers identify fresh therapeutic target for lung cancer Lung cancer individuals whose tumors over-express a cell surface area molecule called CXCR4 do significantly even worse than those who do not, Canadian researchers have found. Their work, reported at the 2nd European Lung Cancer Conference in Geneva, highlights the exciting probability that the molecule could soon become a new target for personalized cancer therapy. CXCR4 can be a receptor that’s on the surface of several different cell types in the body two active ingredients .